Most bought healthcare stocks in Q4 2022

See which Healthcare stocks institutional investors increased the most in Q4 2022, measured as net growth in reported share positions from Q3 2022 into Q4 2022. Notable additions at the top of this list include ELANCO ANIMAL HEALTH INC (ELAN), HALEON PLC-ADR (HLN), FRESENIUS MEDICAL CARE-ADR (FMS), SANOFI-ADR (SNY). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
ELANELANCO ANIMAL HEALTH INC28,968,047$1.04B02113
HLNHALEON PLC-ADR24,403,505$782.38M13207
FMSFRESENIUS MEDICAL CARE-ADR12,983,991$454.64M12104
SNYSANOFI-ADR8,514,514$4.10B04105
SGRYSURGERY PARTNERS INC3,679,954$165.61M01102
GSKGSK PLC-SPON ADR3,555,322$2.31B24208
OSCROSCAR HEALTH INC - CLASS A3,528,031$39.37M02003
ALHCALIGNMENT HEALTHCARE INC2,828,840$44.30M02002
TECHBIO-TECHNE CORP2,287,524$232.96M12003
NVAXNOVAVAX INC1,941,100$12.98K01001
TMOTHERMO FISHER SCIENTIFIC INC1,884,823$3.15B227012
MRVIMARAVAI LIFESCIENCES HLDGS-A1,804,248$8.73K01001
PRMEPRIME MEDICINE INC1,639,984$30.47M10001
JNJJOHNSON & JOHNSON1,535,584$1.58B1310019
OCGNOCUGEN INC1,422,856$1.85K10001
WBAWALGREENS BOOTS ALLIANCE INC1,413,714$35.93M12105
PHGKONINKLIJKE PHILIPS NVR- NY1,343,825$12.40M02002
BAXBAXTER INTERNATIONAL INC1,193,330$17.02M03205
EWEDWARDS LIFESCIENCES CORP1,040,960$2.13M02205
VXRTVAXART INC1,011,816$97210001
AMGNAMGEN INC975,454$158.06M03307
VERVVERVE THERAPEUTICS INC971,971$84.36M01001
AUPHAURINIA PHARMACEUTICALS INC919,400$1.62K01001
IOVAIOVANCE BIOTHERAPEUTICS INC894,947$5.23M01102
ACHCACADIA HEALTHCARE CO INC883,969$421.28M03104
CMPSCOMPASS PATHWAYS PLC808,049$9.88M01102
NRIXNURIX THERAPEUTICS INC747,132$21.81M02002
CDNACAREDX INC645,396$73.60M03003
MNKDMANNKIND CORP549,099$5.94K01001
DVAXDYNAVAX TECHNOLOGIES CORP545,300$6.01K01001
EVHEVOLENT HEALTH INC - A544,050$78.15M01001
ILMNILLUMINA INC528,649$1.04B11003
XRAYDENTSPLY SIRONA INC511,141$310.00M03003
SGMOSANGAMO THERAPEUTICS INC453,400-$1.51K01001
ALLOALLOGENE THERAPEUTICS INC440,100$2.77K10001
PCVXVAXCYTE INC428,777$22.79K01001
CCRNCROSS COUNTRY HEALTHCARE INC427,900$11.24K01001
CLOVCLOVER HEALTH INVESTMENTS CO421,700-$2.67K01001
ACHLACHILLES THERAPEUTICS PL-ADR403,700$25301001
COYACOYA THERAPEUTICS INC392,444$1.86M10001
MRNAMODERNA INC377,302$415.11M11306
ERASERASCA INC354,575$1.53K10001
VTRSVIATRIS INC351,075$10.69M01103
THCTENET HEALTHCARE CORP342,644$38.45M11012
BNTXBIONTECH SE-ADR331,484$49.80K10001
HUMHUMANA INC329,962$105.87M12013
HRTXHERON THERAPEUTICS INC326,500$81610001
BGXXBRIGHT GREEN CORP309,900$14510001
ALGNALIGN TECHNOLOGY INC309,292$758.75M13206
ASRTASSERTIO HOLDINGS INC309,276$2.96M02002
20 symbols with net change in reported shares from tracked managers.0.008.0M15.9M23.9M31.9MNet change in reported shares (tracked managers)ELANHLNFMSSNYSGRYGSKOSCRALHCTECHNVAXTMOMRVIPRMEJNJOCGNWBAPHGBAXEWVXRTSymbol

Frequently asked questions about Most bought healthcare stocks in Q4 2022

  • What are the most bought Healthcare stocks in Q4 2022?

    The most bought healthcare stocks in Q4 2022 are those with the largest increase in reported share counts across tracked institutional investors compared to Q3 2022, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q4 2022?

    Among the managers we track, net additions were largest in companies such as ELANCO ANIMAL HEALTH INC (ELAN), HALEON PLC-ADR (HLN), FRESENIUS MEDICAL CARE-ADR (FMS), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2022).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.